QA: Arena Pharmaceuticals INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001080709_2015_Arena_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 23.696058784235138, 'aggregate_val': 36970000, 'exp_sum': 1497000, 'exp_to_value': {'remainder_Revenues': 1497000}}

Graph

Absolute values for 0001080709, Arena Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 181,896,000
1 IntangibleAssetsNetIncludingGoodwill 8,482,000
2 PropertyPlantAndEquipmentNet 82,919,000
3 remainder_Assets 3,088,000
4 LiabilitiesCurrent 67,362,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,459,493
9 ResearchAndDevelopmentExpense 101,232,090
10 remainder_Expenses 7,212,812
11 remainder_Revenues 50,462,675
12 remainder_NetIncome 142,143,754
13 remainder_ComprehensiveNetIncome -18,022,692
  yvar yval
0 Assets 276,385,000
1 Liabilities 67,362,000
2 Expenses 142,904,395
3 Revenues 50,462,675
4 StockholdersEquity 209,023,000
5 NetIncome 49,702,034
6 ComprehensiveNetIncome 40,690,688
7 BaseVar 348,640,258
8 EconomicCapitalRatiobeforeLimitedLiability 2.89
9 EconomicCapitalRatio 3.61

Edgar->Model Mapping

Feature Distribution

Change over Time